Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

Bullboard Posts

Comment by longondmxon Sep 23, 2014 11:27am

113 Views

Post# 22962284

RE:RE:RE:RE:RE:RE:RE:Short Interest Ratio / Days-to-cover Ratio

Just got a feeling that she is going to pop her top soon! Too many catalysts exists that will easily propel the stock well past all time highs....

The current stock price does not account for any of that. Yes, the price has appreciated since last year, but that was such a ridiculously low valuation that is was inevitable. Even at today's stock price, having a market cap of $40MM - is crazy low. I mean, the company is profitable and improving every day. We should easily be 5x where we currently are today.

Shorting a stock that so undervalued is nuts!

Bullboard Posts

Cross border trading in Canada and Australia